Both the Dow Jones Industrial Average and S&P 500 rallied over the course of the week but felt a huge downward push on Friday. Although the broad markets were at their highest levels on the year, some companies held them back from pushing even higher. Most of the companies that were hurting this week were biotechs, and so we looked into which of the biopharma companies destroyed shareholders separately.
While the following were not the biggest absolute losers of the week, of the active stocks, these all issued or had news that pushed shares down. 24/7 Wall St. has included their recent trading history, as well as the 52-week trading range and the consensus analyst price target.
Dry bulk carrier DryShips Inc. (NASDAQ: DRYS) filed a Form 6-K with the U.S. Securities and Exchange Commission (SEC) reporting that the company has breached certain financial covenants and, as a result, lenders have declared the company in default. The defaults and the poor state of the market for shipping “raise substantial doubt about the company’s ability to continue as a going concern for a reasonable period of time.” According to the filing, the lenders may demand immediate payment of $213,667, an amount that would exceed DryShips’ working capital total of $146,340 at the end of March.
The company noted that it expects to finance its working capital deficit either with cash on hand, cash from operations, proceeds from the sale of its remaining vessels and bank debt. In order to preserve liquidity, the company has “suspended principal repayment and interest payments to preserve cash liquidity and is currently engaged in discussions with its lenders for the restructuring of its debt facilities.”
Over the course of the past week, the stock dropped 45.5%. Shares of DryShips closed Friday at $1.16, with a consensus analyst price target of $8.75 and a 52-week trading range of $1.11 to $19.00.
When Verifone Systems Inc. (NYSE: PAY) reported its fiscal second-quarter financial results after the markets closed on Tuesday, the company said it had $0.47 in earnings per share (EPS) on $532.4 million in revenue. That compared to consensus estimates that called for $0.53 in EPS on revenue of $527.7 million. In the same period of last year, the company posted EPS of $0.44 and $490 million in revenue. In terms of the outlook for the fiscal third quarter, the company expects to have EPS of $0.40 and net revenues of $515 million. Consensus estimates were $0.59 in EPS on $552.11 million in revenue for the coming quarter.
The company is currently conducting a disciplined strategic review to address underperforming businesses and reduce overall operating expense levels. In connection with these plans the company intends to reduce headcount and estimates that these activities in total will generate approximately $30 million of savings in 2017.
Verifone shares fell 27.5% to close out the week at $19.67. The consensus analyst target is $28.47, and the 52-week range of $19.56 to $37.05.
After the markets closed on Wednesday, Restoration Hardware Holdings Inc. (NYSE: RH) reported its most recent quarterly results and effectively stumbled over the bottom line. The company posted a net loss per share of $0.05 on $455.5 million in revenue, versus the consensus estimates that called for EPS of $0.05 and $458.9 million in revenue.
In terms of guidance for the coming fiscal second quarter, Restoration Hardware expects to have EPS in the range of $0.28 to $0.33 and net revenues between $505 million and $520 million. The consensus estimates call for $0.30 in EPS on $512.23 million in revenue for the coming quarter.
Over the past week, the stock dropped 22.0%. Shares closed Friday at $26.56, with a consensus price target of $41.40 and a 52-week range of $26.50 to $106.49.
The fiscal second-quarter financial results for FuelCell Energy Inc. (NASDAQ: FCEL) were released after the markets closed on Wednesday. This energy company said that it had a net loss of $0.56 per share on $1705 million in revenue. Consensus estimates called for a net loss of $0.40 per share on revenue of $34.7 million. Apart from the top and bottom line numbers, expenses for this company are continuing to raise eyebrows, and at the same time FuelCell keeps posting a loss. Undoubtedly, this company hopes that its most recent deal with Exxon will help out with these numbers.
Shares fell 28.2% to close out the week at $5.90, in a 52-week trading range of $4.51 to $13.32. The consensus price target is $12.40.